Total Payments
$14,530
2024 Payments
$1,943
Companies
49
Transactions
779
Medicare Patients
4,875
Medicare Billing
$683,377
Payment Breakdown by Category
Food & Beverage$14,439 (99.4%)
Education$91.84 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,439 | 777 | 99.4% |
| Education | $91.84 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,519 | 166 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,171 | 191 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,005 | 59 | $0 (2024) |
| Genentech USA, Inc. | $668.89 | 56 | $0 (2024) |
| Insmed, Inc. | $539.36 | 28 | $0 (2024) |
| Grifols USA, LLC | $439.44 | 24 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $430.60 | 22 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $338.15 | 19 | $0 (2024) |
| INOGEN, INC. | $309.65 | 18 | $0 (2024) |
| Mylan Specialty L.P. | $300.42 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,943 | 88 | AstraZeneca Pharmaceuticals LP ($460.75) |
| 2023 | $2,130 | 98 | GlaxoSmithKline, LLC. ($474.46) |
| 2022 | $2,299 | 100 | AstraZeneca Pharmaceuticals LP ($1,001) |
| 2021 | $1,936 | 95 | AstraZeneca Pharmaceuticals LP ($670.62) |
| 2020 | $1,579 | 91 | GlaxoSmithKline, LLC. ($480.36) |
| 2019 | $2,036 | 133 | GlaxoSmithKline, LLC. ($635.95) |
| 2018 | $1,491 | 96 | AstraZeneca Pharmaceuticals LP ($362.72) |
| 2017 | $1,116 | 78 | Genentech USA, Inc. ($278.79) |
All Payment Transactions
779 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $79.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: NEUROLOGY | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/29/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,037 | 2,180 | $323,797 | $163,238 |
| 2022 | 16 | 1,135 | 2,138 | $345,027 | $167,773 |
| 2021 | 13 | 1,116 | 1,913 | $371,987 | $192,113 |
| 2020 | 14 | 1,587 | 2,326 | $335,494 | $160,253 |
Total Patients
4,875
Total Services
8,557
Medicare Billing
$683,377
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 393 | 804 | $131,052 | $76,039 | 58.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 58 | 126 | $52,794 | $22,114 | 41.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 66 | 162 | $25,920 | $15,506 | 59.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 205 | $22,550 | $13,461 | 59.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 33 | 268 | $26,800 | $10,060 | 37.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 33 | 253 | $26,818 | $9,356 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $13,000 | $6,276 | 48.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 24 | 87 | $7,395 | $2,726 | 36.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $5,128 | $2,314 | 45.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 33 | $3,696 | $2,059 | 55.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $3,990 | $2,000 | 50.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 31 | 31 | $589.00 | $287.17 | 48.8% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 16 | 16 | $1,200 | $281.60 | 23.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 39 | 39 | $585.00 | $270.73 | 46.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 11 | 12 | $480.00 | $177.48 | 37.0% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 26 | 26 | $1,440 | $165.42 | 11.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 18 | 18 | $360.00 | $146.34 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 336 | 600 | $97,800 | $54,981 | 56.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 93 | 214 | $89,666 | $39,269 | 43.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 95 | 200 | $32,000 | $16,716 | 52.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 162 | 194 | $21,340 | $12,950 | 60.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 41 | 265 | $26,500 | $10,269 | 38.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 37 | 223 | $23,638 | $9,212 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 67 | 67 | $16,750 | $8,037 | 48.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 59 | 59 | $9,676 | $4,616 | 47.7% |
About Dr. William Gill, MD
Dr. William Gill, MD is a Internal Medicine healthcare provider based in Fleming Island, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932171139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Gill, MD has received a total of $14,530 in payments from pharmaceutical and medical device companies, with $1,943 received in 2024. These payments were reported across 779 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($14,439).
As a Medicare-enrolled provider, Gill has provided services to 4,875 Medicare beneficiaries, totaling 8,557 services with total Medicare billing of $683,377. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Fleming Island, FL
- Active Since 02/02/2006
- Last Updated 08/20/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1932171139
Products in Payments
- NUCALA (Biological) $1,599
- FASENRA (Biological) $1,220
- TRELEGY ELLIPTA (Drug) $990.98
- TEZSPIRE (Biological) $778.17
- OFEV (Drug) $587.91
- BREZTRI (Drug) $548.52
- Arikayce (Drug) $539.36
- ACTHAR (Biological) $537.55
- Xolair (Biological) $424.73
- SYMBICORT (Drug) $423.74
- FASENRA (Drug) $387.50
- DUPIXENT (Biological) $351.20
- ANORO (Drug) $329.15
- AVYCAZ (Drug) $275.95
- XYWAV (Drug) $251.66
- Esbriet (Biological) $244.16
- Prolastin-C (Biological) $223.24
- INOGEN (Device) $210.10
- Prolastin-C Liquid (Biological) $193.56
- CHARTIS CATHETER (Device) $185.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fleming Island
Dr. Kabir Yousuf, Md, MD
Internal Medicine — Payments: $20,341
Internal Medicine $20,341
Satish Shanbhag, Md,Mph, MD,MPH
Internal Medicine — Payments: $15,799
Internal Medicine $15,799
Dr. Stuart Shah, Md, MD
Internal Medicine — Payments: $5,801
Internal Medicine $5,801
Dr. Chetan Hampole, M.d, M.D
Internal Medicine — Payments: $5,719
Internal Medicine $5,719
Dr. William Linville, Do, DO
Internal Medicine — Payments: $5,019
Internal Medicine $5,019
Vikas Patel, M.d, M.D
Internal Medicine — Payments: $3,131
Internal Medicine $3,131